Urinary cytokines: clinically useful markers of chronic renal disease progression?

被引:9
作者
Wong, WC [1 ]
Singh, AK [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA
关键词
D O I
10.1097/00041552-200111000-00012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Many factors that drive glomerular and tubulointerstitial fibrogenesis have been identified. These include hemodynamic factors, chemokines, inflammatory mediators, cytokines, and lipids. These strides in knowledge are important in identifying those patients at increased risk of progressive renal disease as well as in developing targets for therapeutic interventions. Identifying 'progressors' is crucial since the distribution of the slope of the glomerular filtration rate of patients with chronic kidney disease is not normal. Some patients appear to progress very rapidly, such as those with diabetes, whereas other patients fail to progress at all. Developing strategies targeted at identifying the fast from the slow progressors is therefore of paramount importance if we are to deploy resources rationally in the management of patients with chronic kidney disease. The use of urinary cytokine markers as predictors of progression of renal disease is reviewed in this paper. Curr Opin Nephrol Hypertens 10:807-811. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:807 / 811
页数:5
相关论文
共 53 条
[1]   How renal cytokines and growth factors contribute to renal disease progression [J].
Benigni, A ;
Remuzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (01) :S21-S24
[2]  
Bohle A, 1990, Cytokine, V2, P175, DOI 10.1016/1043-4666(90)90013-J
[3]   Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients [J].
Bologa, RM ;
Levine, DM ;
Parker, TS ;
Cheigh, JS ;
Serur, D ;
Stenzel, KH ;
Rubin, AL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (01) :107-114
[4]   Effect of maximal reduction of angiotensin in renal fibrosis: Bad news-good news from a pediatric mouse - Discussion [J].
Border, WA ;
Noble, NA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :773-775
[5]  
BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104
[6]  
CHANDRAKER A, 1998, 17 ANN M AM SOC TRAN, P137
[7]  
DOHI K, 1991, CLIN NEPHROL, V35, P1
[8]  
EGIDO J, 1993, KIDNEY INT, V43, pS59
[9]   GLOMERULAR CELL-PROLIFERATION AND PDGF EXPRESSION PRECEDE GLOMERULOSCLEROSIS IN THE REMNANT KIDNEY MODEL [J].
FLOEGE, J ;
BURNS, MW ;
ALPERS, CE ;
YOSHIMURA, A ;
PRITZL, P ;
GORDON, K ;
SEIFERT, RA ;
BOWENPOPE, DF ;
COUSER, WG ;
JOHNSON, RJ .
KIDNEY INTERNATIONAL, 1992, 41 (02) :297-309
[10]  
FLOEGE J, 1995, MINER ELECTROL METAB, V21, P271